• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种突变的小鼠还原型叶酸载体(RFC1),对叶酸的亲和力增加,对甲氨蝶呤的亲和力降低,且其转运功能需要必需阴离子。

A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.

作者信息

Zhao R, Assaraf Y G, Goldman I D

机构信息

Departments of Medicine and Molecular Pharmacology, and the Albert Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

J Biol Chem. 1998 Jul 24;273(30):19065-71. doi: 10.1074/jbc.273.30.19065.

DOI:10.1074/jbc.273.30.19065
PMID:9668089
Abstract

In an ongoing study of structure-function relationships of the murine reduced folate carrier 1 (RFC1), a glutamate to lysine mutation at amino acid 45 was identified in a methotrexate (MTX)-resistant L1210 clonal variant in which MTX and 5-formyltetrahydrofolate (5-CHO-THF) influx was markedly decreased. The characteristics of the mutated carrier, RFC1-E45K, were studied by cDNA transfection into the murine MTXrA line in which endogenous carrier is not functional. Folic acid influx doubled in the transfectant MTXrA-E45K as compared with L1210 or MTXrA cells; in contrast, MTX and 5-CHO-THF influx was only 14 and 27% that of L1210 cells, respectively. 5-CHO-THF influx in MTXrA-E45K cells was characterized by a 12- and 3.6-fold decrease in influx Vmax and Kt respectively, relative to L1210 cells. The folic acid influx Ki in L1210 cells was more than 50-fold greater than that of MTX based upon inhibition of 5-CHO-THF influx. In comparison, the mutated carrier had comparable affinities for folic acid and MTX in MTXrA-E45K cells due to a 7-fold decrease in the folic acid influx Ki and 7-fold increase in the MTX influx Ki. Transport via native RFC1 is inhibited by a variety of anions in L1210 cells associated with an increase in influx Kt. However, influx of 5-CHO-THF in MTXrA-E45K cells in a HEPES buffer (9 mM chloride) was decreased by 70% due to a 3-fold fall in the Vmax. In the complete absence of chloride (K+-HEPES-sucrose buffer) 5-CHO-THF influx was only 10% that in HBS buffer. 5-CHO-THF influx was restored by addition of chloride, fluoride, or nitrate but not by sulfate, phosphate, or ATP which were all inhibitory over a broad range of concentrations. The data suggest that substitution of a positive for a negative amino acid at position 45 results in the loss of RFC1 mobility in the absence of small inorganic anions that bind to, and neutralize the positive charge on, the lysine residue. Inhibition by higher charged anions may be due to interactions at another carrier site present in both the mutated and wild type carrier. This and other studies suggest that amino acids in the first predicted transmembrane domain play an important role in determining the spectrum of affinities for, and mobility of, RFC1 and is a cluster region for mutations when cells are placed under selective pressure with antifolates that utilize RFC1 as the major route of entry into mammalian cells.

摘要

在一项正在进行的关于小鼠还原型叶酸载体1(RFC1)结构-功能关系的研究中,在一种甲氨蝶呤(MTX)耐药的L1210克隆变体中,发现第45位氨基酸发生了谷氨酸到赖氨酸的突变,在该变体中MTX和5-甲酰四氢叶酸(5-CHO-THF)的内流显著减少。通过将cDNA转染到内源性载体无功能的小鼠MTXrA细胞系中,研究了突变载体RFC1-E45K的特性。与L1210或MTXrA细胞相比,转染的MTXrA-E45K细胞中叶酸内流增加了一倍;相比之下,MTX和5-CHO-THF内流分别仅为L1210细胞的14%和27%。与L1210细胞相比,MTXrA-E45K细胞中5-CHO-THF内流的特征是内流Vmax和Kt分别降低了12倍和3.6倍。基于对5-CHO-THF内流的抑制,L1210细胞中叶酸内流的Ki比MTX大50倍以上。相比之下,由于叶酸内流Ki降低了7倍,MTX内流Ki增加了7倍,突变载体在MTXrA-E45K细胞中对叶酸和MTX具有相当的亲和力。在L1210细胞中,通过天然RFC1的转运受到多种阴离子的抑制,这与内流Kt的增加有关。然而,在HEPES缓冲液(9 mM氯离子)中,MTXrA-E45K细胞中5-CHO-THF的内流因Vmax下降3倍而减少了70%。在完全没有氯离子的情况下(K+-HEPES-蔗糖缓冲液),5-CHO-THF内流仅为HBS缓冲液中的10%。添加氯离子、氟离子或硝酸根可恢复5-CHO-THF内流,但添加硫酸根、磷酸根或ATP则不能恢复,这些在广泛的浓度范围内均具有抑制作用。数据表明,在第45位用正氨基酸取代负氨基酸会导致在没有与赖氨酸残基结合并中和其正电荷的小无机阴离子的情况下,RFC1的流动性丧失。带更高电荷的阴离子的抑制作用可能是由于在突变型和野生型载体中都存在的另一个载体位点上的相互作用。这项研究和其他研究表明,第一个预测的跨膜结构域中的氨基酸在确定RFC1的亲和力谱和流动性方面起着重要作用,并且当细胞在以RFC1作为进入哺乳动物细胞的主要途径的抗叶酸药物的选择压力下时,该区域是突变的聚集区。

相似文献

1
A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.一种突变的小鼠还原型叶酸载体(RFC1),对叶酸的亲和力增加,对甲氨蝶呤的亲和力降低,且其转运功能需要必需阴离子。
J Biol Chem. 1998 Jul 24;273(30):19065-71. doi: 10.1074/jbc.273.30.19065.
2
Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.通过在还原型叶酸载体预测的第八个跨膜结构域中用苯丙氨酸替代丝氨酸,来区分还原型叶酸和甲氨蝶呤作为转运底物的差异。
Biochem Pharmacol. 1999 Nov 15;58(10):1615-24. doi: 10.1016/s0006-2952(99)00257-9.
3
A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.一种还原型叶酸载体突变在鼠白血病细胞中产生载体迁移率的底物依赖性改变以及甲氨蝶呤耐药性,同时保持在5-甲酰四氢叶酸存在下的生长。
J Biol Chem. 1998 Apr 3;273(14):7873-9. doi: 10.1074/jbc.273.14.7873.
4
Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.还原型叶酸载体(RFC1,一种阴离子交换蛋白)过表达对小鼠L1210白血病细胞中浓缩转运的影响。
J Biol Chem. 1997 Aug 22;272(34):21207-12. doi: 10.1074/jbc.272.34.21207.
5
Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.对具有缺陷的还原型叶酸载体功能的小鼠L1210白血病细胞中由低pH途径介导的叶酸转运的表征。
Biochem Pharmacol. 1998 May 1;55(9):1505-12. doi: 10.1016/s0006-2952(97)00673-4.
6
Role of the amino acid 45 residue in reduced folate carrier function and ion-dependent transport as characterized by site-directed mutagenesis.
Mol Pharmacol. 2000 Feb;57(2):317-23.
7
Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.区分L1210白血病细胞中叶酸受体α介导的转运和还原型叶酸载体介导的转运。
J Biol Chem. 1995 Apr 7;270(14):7842-9. doi: 10.1074/jbc.270.14.7842.
8
Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.小鼠L1210白血病细胞中还原型叶酸载体与叶酸受体转运特性的比较。
Biochem Pharmacol. 1995 Oct 12;50(8):1287-94. doi: 10.1016/0006-2952(95)94097-y.
9
Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier.小鼠还原型叶酸载体跨膜结构域中保守精氨酸和赖氨酸残基功能作用的突变分析
Mol Pharmacol. 2001 May;59(5):1022-8. doi: 10.1124/mol.59.5.1022.
10
Residues 45 and 404 in the murine reduced folate carrier may interact to alter carrier binding and mobility.小鼠还原型叶酸载体中的45位和404位残基可能相互作用,从而改变载体的结合和迁移能力。
Biochim Biophys Acta. 2003 Jun 27;1613(1-2):49-56. doi: 10.1016/s0005-2736(03)00136-6.

引用本文的文献

1
Structural basis of thiamine transport and drug recognition by SLC19A3.SLC19A3介导硫胺素转运及药物识别的结构基础
Nat Commun. 2024 Oct 2;15(1):8542. doi: 10.1038/s41467-024-52872-8.
2
Methotrexate recognition by the human reduced folate carrier SLC19A1.人源二氢叶酸还原酶载体 SLC19A1 对甲氨蝶呤的识别。
Nature. 2022 Sep;609(7929):1056-1062. doi: 10.1038/s41586-022-05168-0. Epub 2022 Sep 7.
3
The anti-tumor activity of pralatrexate (PDX) correlates with the expression of RFC and DHFR mRNA in preclinical models of multiple myeloma.
在多发性骨髓瘤的临床前模型中,普拉曲沙(PDX)的抗肿瘤活性与RFC和DHFR mRNA的表达相关。
Oncotarget. 2020 May 5;11(18):1576-1589. doi: 10.18632/oncotarget.27516.
4
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment.儿童急性淋巴细胞白血病巩固治疗阶段甲氨蝶呤反应的药物基因组学标志物
Genes (Basel). 2020 Apr 24;11(4):468. doi: 10.3390/genes11040468.
5
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.药物基因组学在降低急性淋巴细胞白血病维持治疗期间毒性方面的前景。
Genomics Proteomics Bioinformatics. 2017 Apr;15(2):82-93. doi: 10.1016/j.gpb.2016.11.003. Epub 2017 Apr 6.
6
Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.主要易化型叶酸转运蛋白SLC19A1和SLC46A1的生物学特性
Curr Top Membr. 2014;73:175-204. doi: 10.1016/B978-0-12-800223-0.00004-9.
7
The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.主要促进叶酸转运蛋白溶质载体 19A1 和溶质载体 46A1:生物学及在癌症抗叶酸化疗中的作用。
Drug Metab Dispos. 2014 Apr;42(4):632-49. doi: 10.1124/dmd.113.055723. Epub 2014 Jan 6.
8
SLC19A1 pharmacogenomics summary.SLC19A1药物基因组学概述。
Pharmacogenet Genomics. 2010 Nov;20(11):708-15. doi: 10.1097/FPC.0b013e32833eca92.
9
Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.还原型叶酸载体的结构与功能——主要易化子超家族哺乳动物营养转运体的范例
Vitam Horm. 2008;79:145-84. doi: 10.1016/S0083-6729(08)00405-6.
10
Role of lysine 411 in substrate carboxyl group binding to the human reduced folate carrier, as determined by site-directed mutagenesis and affinity inhibition.通过定点诱变和亲和抑制确定赖氨酸411在底物羧基与人类还原型叶酸载体结合中的作用。
Mol Pharmacol. 2008 Apr;73(4):1274-81. doi: 10.1124/mol.107.043190. Epub 2008 Jan 8.